Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.24 AUD | +0.28% | +3.87% | +17.72% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.72% | 383M | |
+28.67% | 46.63B | |
+19.30% | 22.49B | |
+20.11% | 14.49B | |
+0.55% | 12.98B | |
+46.16% | 12.16B | |
-2.44% | 7.69B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.15B |
- Stock
- Equities
- Stock Mayne Pharma Group Limited - Australian S.E.
- News Mayne Pharma Group Limited
- Mayne Pharma Names New CFO; Shares Jump 5%